"2.02 quarters of funding available so CR likely in July August time. Clinical studies rarely meet forecast end dates."
They are planning to go commercial in Syd/Mel in Dec24 and expecting those profits to fund expansion into rest of Aus through H1 CY25.
You don't think they can stretch the cash to Dec when the revenues start coming in?
I am also not sure who is funding the US study.
"2.02 quarters of funding available so CR likely in July August...
Add BDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
-0.005(4.35%) |
Mkt cap ! $27.75M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 11.0¢ | $7.843K | 71.29K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 36514 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 11.00am 24/05/2024 (20 minute delay) ? |
|
|||||
|
Last
11.5¢ |
Change
-0.005 ( 4.55 %) |
||||
| Open | High | Low | Volume | ||
| 10.5¢ | 11.5¢ | 10.5¢ | 17649 | ||
| Last updated 11.27am 24/05/2024 ? | |||||
| BDX (ASX) Chart |